Search

everythinglearnresearchcommunity

for

Search:↓

One-third of COVID-19 patients had long-term symptoms like hair loss and fatigue, with women, older individuals, blood group B, smokers, and those with more virus exposure at higher risk.

A COVID-19 patient had unusual nail discoloration and nail separation possibly due to the virus's effects on small blood vessels.

Tailoring COVID-19 measures to risk levels in the military improves health and readiness.

Skin symptoms linked to COVID-19 are hard to confirm, and more testing is needed to identify which are truly caused by the virus.

Older, obese people with many COVID-19 symptoms are more likely to suffer from severe long-term COVID-19 effects.

Long COVID-19 patients with skin pain might have a nerve condition that responds to a medication called gabapentin.

Hydroxychloroquine, nitazoxanide, and ivermectin were similarly effective in treating early COVID-19.

Early treatment with certain drug combinations improved COVID-19 outcomes and prevented severe disease in males, including those at higher risk.

Most severe COVID-19 patients in Mexico experienced long-lasting symptoms that worsened their quality of life.

The COVID-19 pandemic led to fewer skin checks and skin cancer diagnoses in Australia in 2020.

A woman's hair loss after COVID-19 was likely due to a mix of pressure-induced alopecia and acute telogen effluvium.

Most COVID-19 survivors developed post-acute symptoms, especially if they had been in the ICU, but the severity of initial infection didn't predict these symptoms.

Alopecia after COVID-19 negatively impacts quality of life, especially vitality.

The COVID-19 pandemic led to fewer dermatology visits, older and more male patients, and more stress-related skin issues.

The COVID-19 pandemic led to more hair loss and skin irritation among Iraqi women, with some skin conditions increasing and others decreasing.

Women with PCOS may have a higher risk of severe COVID-19 due to hormonal imbalances and vitamin D deficiency.

Post-COVID-19 hair loss is likely due to stress and inflammation.

The COVID-19 pandemic has caused a 57% increase in interest in facial cosmetic procedures, leading to calls for better industry regulation and professional standards.

Men with male pattern baldness had worse COVID-19 symptoms, but early treatment with certain drugs improved outcomes for all.

Trichoscopy and histopathology can help identify post-COVID-19 hair loss.

Post-COVID-19 syndrome is complex, affects 5%-10% of people, and requires better research and global collaboration for treatment.

Many COVID-19 survivors still face health issues months later, so ongoing medical support is important.

Anemia increases the risk of hair loss in post-COVID-19 survivors.

Complete COVID-19 vaccination reduces the risk of long COVID.

The pandemic increased interest in aesthetic treatments due to more online meetings.

Post-COVID-19 hair loss is different from androgenetic alopecia and can be identified by lower copper and higher selenium levels.

Post-COVID-19 hair loss is not linked to vitamin D or quality of life but is linked to hair graying.

Vitamin D supplements significantly improved post-COVID-19 symptoms in deficient patients.

Homoeopathy has helped treat hair loss after Covid-19, considering the patient's overall condition.